This author has yet to write their bio.
Meanwhile lets just say that we are proud Bettina Heindl contributed a whooping 20 entries.
The EURIPID collaboration held its annual meeting of the Board of Participants (BoP) in Brussels on 4-5th June 2024. A total of representatives of 19 BoP members gathered at the Belgian Institute for Health and Disability Insurance (RIZIV INAMI). At the BoP meeting, besides the update on current matters of EURIPID and the presentation of […]
The EURIPID database constitutes more than 30 Mio. data points on prices of medicinal products and since 2019 also information on volumes and the existence of Managed Entry Agreements (MEA) in EURIPID member states. This makes EURIPID a valuable source of information for analyses in the field of pharmaceutical pricing & reimbursement, beyond purposes of […]
On 25 and 26 April 2024 the 5th PPRI Conference of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies was held at the Palais Niederösterreich in Vienna. More than 250 participants from more than 40 countries discussed about burning challenges related to equitable and affordable access to medicines worldwide (https://ppri.goeg.at/news1). On the second […]
This year the EURIPID collaboration will organise a series of webinars to present current important developments in the field for pharmaceutical pricing & reimbursement. The second webinar will be held on Tuesday, 21 May 2024, 1 PM, and the target group of this Webinar are (1) members of the EURIPID collaboration, (2) National Competent Authorities […]
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, located at Gesundheit Österreich GmbH (GÖG/Austrian National Public Health Institute) in Vienna organise this year 5th PPRI Conference. From Thursday, 25 April till Friday 26 April Health experts will discuss at the Palais Niederösterreich in Vienna about „Ensuring access to affordable medicines through innovative policies“. […]
This year the EURIPID collaboration will organise a series of webinars to present current important developments in the field for pharmaceutical pricing & reimbursement. The first webinar will be held on Wednesday, 28 February 2024, 10 AM, and the target group of this Webinar are members of the EURIPID collaboration as well as National Competent […]
On 19 October 2023 the EURIPID collaboration held its annual Meeting of the Board of Participants (BoP). EURIPID members from 20 countries gathered at the premises of the Polish Agency for Health Technology Assessment and Tariff System (Agencja Oceny Technologii Medycznych i Taryfikacji, AOTMiT) in Warsaw. The meeting was facilitated by Momir Radulović, the Director […]
At the 72nd session of the WHO Regional Committee for Europe in September 2022 it was agreed to establish a formal stakeholder collaboration platform – the WHO/Europe Access to Novel Medicines Platform (NMP). The aim of the platform is to identify concrete actions, including pilot proposals, to improve affordable and equitable patient access to effective, […]
EURIPID is proud to announce Croatias re-entry into EURIPID. After careful negotations and fullfilling the necessary reqirements, Croatia has once again become a full-member of EURPID. Joining EURIPID brings numerous benefits. EURIPID supports countries by sharing pricing information on a wide range of pharmaceuticals. It helps policymakers to make informed decisions, monitor price developments and […]
On 14 February 2023 the Organisation for Economic Co-operation and Development (OECD) published a health working paper on “Exploring the feasibility of monitoring access to novel medicine“. The OECD undertook a pilot study in EU Member States that aimed to determine the utility and feasibility of routine, cross-national monitoring of access to medicines across multiple […]
The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!